Login to Your Account



Vicuron Files Another NDA For Antifungal Drug Anidulafungin

By Aaron Lorenzo


Monday, August 22, 2005
Vicuron Pharmaceuticals Inc., one of Pfizer Inc.'s latest pickups, last week submitted a new drug application for anidulafungin to the FDA, right on schedule. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription